Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98.5M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
31.5M
-
Shares change
-
+272K
-
Total reported value, excl. options
-
$659M
-
Value change
-
+$8.49M
-
Number of buys
-
41
-
Number of sells
-
-26
-
Price
-
$20.91
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q3 2021
84 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.5M shares
of 98.5M outstanding shares and own 32.02% of the company stock.
Largest 10 shareholders include FMR LLC (5.9M shares), EcoR1 Capital, LLC (3.47M shares), BlackRock Inc. (2.41M shares), ORBIMED ADVISORS LLC (2.34M shares), VANGUARD GROUP INC (1.6M shares), VICTORY CAPITAL MANAGEMENT INC (1.55M shares), ArrowMark Colorado Holdings LLC (1.25M shares), WELLS FARGO & COMPANY/MN (1.21M shares), STATE STREET CORP (1.06M shares), and Invus Financial Advisors, LLC (1.01M shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.